Alteplase is a recombinant tissue plasminogen activator used as a potent thrombolytic agent to treat conditions involving blood clots, such as acute ischemic stroke, myocardial infarction, acute massive… Read more
Alteplase is a recombinant tissue plasminogen activator used as a potent thrombolytic agent to treat conditions involving blood clots, such as acute ischemic stroke, myocardial infarction, acute massive pulmonary embolism, and catheter occlusions. This therapeutic protein functions by converting plasminogen to plasmin, effectively dissolving fibrin clots to restore blood flow. Laboratories utilize these high-quality reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds, to perform rigorous impurity profiling and method validation. By incorporating these specialized analytical tools into quality control protocols, researchers can ensure the consistency, safety, and efficacy of the drug product throughout its lifecycle. These reference materials are essential for identifying degradation products and verifying the accurate quantification of the active pharmaceutical ingredient during stability testing and routine batch analysis.